The short answer: CAR-T cell therapy in India typically costs around $45,000, compared to $400,000 or more in the US — one of the starkest cost gaps in medical tourism, for one of the most advanced treatments currently available for certain blood cancers.
What CAR-T cell therapy actually is
CAR-T (chimeric antigen receptor T-cell) therapy involves collecting a patient’s own T-cells, genetically modifying them in a laboratory to better recognise and attack cancer cells, and infusing them back into the patient. It is typically considered for specific blood cancers — certain types of leukaemia, lymphoma, and multiple myeloma — that haven’t responded adequately to standard treatment, rather than as a first-line option.
Cost comparison
| India | USA | |
|---|---|---|
| CAR-T cell therapy | $45,000 | $400,000+ |
This figure typically covers cell collection, laboratory modification, and infusion, but confirm what’s included versus billed separately — pre-treatment conditioning chemotherapy and the hospital stay around infusion are sometimes itemised individually.
Where it’s available
Max Healthcare, Delhi. Offers CAR-T for leukaemia, lymphoma, and multiple myeloma, with patients travelling specifically from Nigeria, Kenya, Bangladesh, and Uganda for a treatment either unavailable or unaffordable at home.
HCG Cancer Centre, Bangalore. One of India’s pioneering centres in CAR-T therapy for blood malignancies, backed by in-house genomic labs supporting the detailed diagnostic work CAR-T eligibility requires.
Who is a candidate
CAR-T is typically considered for specific blood cancers that haven’t responded to standard treatment — your existing oncologist’s reports, including prior treatment history and current disease status, will determine eligibility, reviewed remotely by the Indian oncology team before you travel. Not every blood cancer patient is a candidate, and eligibility depends heavily on the specific cancer type and how it has responded to prior therapy.
What the process involves, step by step
- Share your full oncology history, including prior treatments and current disease status, for remote eligibility review.
- If eligible, travel to India for T-cell collection (apheresis), a relatively quick outpatient-style procedure.
- Your cells are sent for laboratory modification, which typically takes one to several weeks depending on the specific product and manufacturing process.
- You may receive bridging chemotherapy during the manufacturing wait to keep your disease controlled.
- Once modified cells are ready, you receive conditioning chemotherapy followed by the CAR-T infusion itself.
- A close monitoring period follows, watching specifically for immune-related side effects that can occur with this therapy.
What to prepare before reaching out
Have your complete haematology and oncology records ready, including diagnosis date, all prior treatments and their outcomes, and recent disease-status testing. CAR-T eligibility review depends heavily on this full history, not just a current snapshot.
CAR-T therapy made in India
In 2023, India approved its first indigenously developed CAR-T cell therapy, which has helped make this treatment more accessible within the country. Availability, eligibility and cost still vary by centre and by cancer type, so patients should ask each treating centre which CAR-T products it uses and for which conditions.
Questions to ask a CAR-T centre
- Am I a suitable candidate, and what are the alternatives?
- Which CAR-T product would be used, and how long does manufacturing take?
- How long must I stay near the hospital after the infusion?
- How are side effects such as cytokine release syndrome monitored and treated?
- What is included in the estimate, and what could add to it?
Planning the stay
CAR-T treatment involves several stages, from collecting the patient’s cells to infusion and close monitoring afterwards, so families should plan for several weeks near the treating centre. A caregiver usually needs to be present throughout. See budgeting for stay and food near the hospital and our guide to bone marrow transplant in India.
Costs beyond the therapy itself
Besides the CAR-T product and hospital stay, families should budget for tests before treatment, possible intensive care if side effects are severe, medicines and follow-up visits, and accommodation near the centre for the monitoring period.
Frequently asked questions
How long does the full CAR-T process take, including recovery? It typically involves several weeks in India — cell collection, manufacturing time, infusion, and a close monitoring period afterward for treatment-related side effects.
What side effects should I expect? CAR-T therapy carries specific risks including immune-related reactions that require close monitoring — your oncology team will explain what to expect and how it’s managed for your specific case.
Is CAR-T guaranteed to work? No cancer treatment can be guaranteed — response rates vary by cancer type and individual case, and this should be discussed directly and honestly with your oncology team based on your specific diagnosis.
Can I return home during the manufacturing wait period? This depends on your specific case and disease status — some patients may need to remain in India, particularly if bridging therapy is required; discuss this with your care team.
Wondering if you’re a candidate? Share your oncology reports for a remote specialist review.